Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization

110Citations
Citations of this article
192Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cancer cells constantly adapt to oxidative phosphorylation (OXPHOS) suppression resulting from hypoxia or mitochondria defects. Under the OXPHOS suppression, AMP-activated protein kinase (AMPK) regulates global metabolism adjustments, but its activation has been found to be transient. Whether cells can maintain cellular ATP homeostasis and survive beyond the transient AMPK activation is not known. Here, we study the bioenergetic adaptation to the OXPHOS inhibitor oligomycin in a group of cancer cells.Wefound that oligomycin at 100 ng/ml completely inhibits OXPHOS activity in 1 h and induces various levels of glycolysis gains by 6 h, from which we calculate the bioenergetic organizations of cancer cells. In glycolysis-dominant cells, oligomycin does not induce much energy stress as measured by glycolysis acceleration, ATP imbalance, AMPKactivation,AMPKsubstrate acetyl-CoA carboxylase phosphorylation at Ser79, and cell growth inhibition. In OXPHOS-dependent LKB1 wild type cells, oligomycin induces 5-8% ATP drops and transient AMPK activation during the initial 1-2 h. After AMPK activation is completed, oligomycininduced increase of acetyl-CoA carboxylase phosphorylation at Ser79 is still detected, and cellular ATP is back at preoligomycin treatment levels by sustained elevation of glycolysis. Cell growth, however, is inhibited without an increase in cell death and alteration in cell cycle distribution. In OXPHOS-dependent LKB1-null cells, no AMPK activation by oligomycin is detected, yet cells still show a similar adaptation. We also demonstrate that the adaptation to oligomycin does not invoke activation of hypoxia-induced factor. Our data suggest that cancer cells may grow and survive persistent OXPHOS suppression through an as yet unidentified regulatory mechanism. © 2010 by The American Society for Biochemistry and Molecular Biology, Inc.

References Powered by Scopus

On the origin of cancer cells

11022Citations
N/AReaders
Get full text

Role of AMP-activated protein kinase in mechanism of metformin action

4820Citations
N/AReaders
Get full text

Why do cancers have high aerobic glycolysis?

4092Citations
N/AReaders
Get full text

Cited by Powered by Scopus

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

646Citations
N/AReaders
Get full text

Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B<sup>high</sup> cells

534Citations
N/AReaders
Get full text

A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo

458Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Hao, W., Chang, C. P. B., Tsao, C. C., & Xu, J. (2010). Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization. Journal of Biological Chemistry, 285(17), 12647–12654. https://doi.org/10.1074/jbc.M109.084194

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 88

68%

Researcher 25

19%

Professor / Associate Prof. 15

12%

Lecturer / Post doc 2

2%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 57

48%

Biochemistry, Genetics and Molecular Bi... 41

34%

Medicine and Dentistry 15

13%

Pharmacology, Toxicology and Pharmaceut... 7

6%

Save time finding and organizing research with Mendeley

Sign up for free